The relationship of vitamin D status to cardiovascular risk factors and amputation risk in veterans with peripheral arterial disease

Journal of the American Medical Directors Association

Volumn 12, Issue 1, 2011, Pages 58-61

  Gaddipati, Vamsi C ^a   Bailey, Beth A ^a   Kuriacose, Reena ^a   Copeland, Rebecca J ^a   Manning, Todd ^b   Peiris, Alan N ^a,b  

^a East Tennessee State University   (United States)

^b James H Quillen VA Medical Center   (United States)

Author keywords

Amputation; Peripheral arterial disease; Vitamin D deficiency

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VITAMIN D;

ADULT; AGED; AMPUTATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OBESITY; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; VETERAN; VITAMIN D DEFICIENCY;

EID: 78650620177     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.02.006     Document Type: Article

References (33)

1. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
2. Stehouwer C.D., Clement D., Davidson C., et al. Peripheral arterial disease: A growing problem for the internist. Eur J Intern Med 2009, 20:132-138.
3. Hiatt W.R., Hoag S., Hamman R.F. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995, 91:1472-1479.
4. Flu H., van der Hage J.H., Knippenberg B., et al. Treatment for peripheral arterial obstructive disease: An appraisal of the economic outcome of complications. J Vasc Surg 2008, 48:368-376.
5. Bianchi C., Penno G., Pancani F., et al. Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes. Diabetes Res Clin Pract 2007, 78:246-253.
6. Holick M.F. Sunlight, UV-radiation, vitamin D and skin cancer: How much sunlight do we need?. Adv Exp Med Biol 2008, 624:1-15.
7. Drinka P.J., Krause P.F., Nest L.J., Goodman B.M. Determinants of vitamin D levels in nursing home residents. J Am Med Dir Assoc 2007, 8:76-79.
8. Peiris A.N., Bailey B.A., Manning T. The relationship of vitamin D deficiency to health care costs in veterans. Mil Med 2008, 173:1214-1218.
9. Li Y.C., Kong J., Wei M., et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
10. O'Connell T.D., Berry J.E., Jarvis A.K., et al. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997, 272:H1751-1758.
11. Mitsuhashi T., Morris R.C., Ives H.E. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991, 87:1889-1895.
12. Watson K.E., Abrolat M.L., Malone L.L., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96:1755-1760.
13. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006, 65:593-597.
14. Kim D.H., Sabour S., Sagar U.N., et al. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102:1540-1544.
15. Melamed M.L., Muntner P., Michos E.D., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008, 28:1179-1185.
16. Reis J.P., Michos E.D., von Muhlen D., Miller E.R. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008, 88:1469-1477.
17. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
18. Giovannini I., Chiarla C., Giuliante F., et al. The relationship between albumin, other plasma proteins and variables, and age in the acute phase response after liver resection in man. Amino Acids 2006, 31:463-469.
19. Forouhi N.G., Luan J., Cooper A., et al. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008, 57:2619-2625.
20. Major G.C., Alarie F., Dore J., et al. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007, 85:54-59.
21. de Boer I.H., Kestenbaum B., Shoben A.B., et al. 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009, 20:1805-1812.
22. Shroff R., Egerton M., Bridel M., et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008, 19:1239-1246.
23. Suzuki Y., Ichiyama T., Ohsaki A., et al. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol 2009, 113:134-138.
24. London G.M., Guerin A.P., Verbeke F.H., et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007, 18:613-620.
25. Tukaj C. Enhanced proliferation of aortal smooth muscle cells treated by 1,25(OH)2D3 in vitro coincides with impaired formation of elastic fibres. Int J Exp Pathol 2008, 89:117-124.
26. Barreto D.V., Barreto F.C., Liabeuf S., et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:1128-1135.
27. Freundlich M., Quiroz Y., Zhang Z., et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 2008, 74:1394-1402.
28. Rigby W.F., Denome S., Fanger M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 1987, 79:1659-1664.
29. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30:980-986.
30. Kasuga H., Hosogane N., Matsuoka K., et al. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun 2002, 297:1332-1338.
31. Briese S., Wiesner S., Will J.C., et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 2006, 21:1906-1914.
32. Davis W., Rockway S., Kwasny M. Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults. Am J Ther 2009, 16:326-332.
33. Pilz S., Dobnig H., Fischer J.E., et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008, 39:2611-2613.